Repare Therapeutics (NASDAQ:RPTX – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research report issued on Thursday, Benzinga reports. They presently have a $10.00 target price on the stock. HC Wainwright’s price target would indicate a potential upside of 187.36% from the stock’s previous close. Separately, […]
HC Wainwright reiterated their buy rating on shares of Repare Therapeutics (NASDAQ:RPTX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price objective on the stock. Separately, Bloom Burton lowered Repare Therapeutics from a buy rating to an accumulate rating in a research […]
HC Wainwright restated their buy rating on shares of Repare Therapeutics (NASDAQ:RPTX – Free Report) in a research report sent to investors on Monday, Benzinga reports. They currently have a $25.00 price target on the stock. HC Wainwright also issued estimates for Repare Therapeutics’ Q4 2023 earnings at $0.02 EPS, FY2023 earnings at ($1.55) EPS, […]
Repare Therapeutics Inc. (NASDAQ:RPTX – Free Report) – Analysts at HC Wainwright boosted their FY2023 earnings per share (EPS) estimates for shares of Repare Therapeutics in a research note issued to investors on Monday, November 20th. HC Wainwright analyst R. Burns now expects that the company will post earnings per share of ($1.55) for the […]
Repare Therapeutics (NASDAQ:RPTX – Free Report) had its target price lifted by Stifel Nicolaus from $16.00 to $17.00 in a report issued on Monday, Marketbeat.com reports. They currently have a buy rating on the stock. Separately, HC Wainwright reduced their target price on shares of Repare Therapeutics from $26.00 to $25.00 and set a buy […]